BioAdvance News

Immunome Announces Creation of COVID-19 Advisory Board

By WebmasterSeptember 16, 2020November 1st, 2024No Comments

Immunome Announces Creation of COVID-19 Advisory Board
Advisory Board to help guide development and clinical testing of biosynthetic convalescent plasma as a potential COVID-19 treatment and prevention of disease

See more here

Previous PostVenatorx Pharmaceuticals Names William Sargent Senior Vice President, Commercial Strategy
Next PostMelior Pharmaceuticals Awarded Grant for Advancing Pulmonary Therapeutic in COVID-19 Phase 2 Clinical Trial

Immunome Announces Creation of COVID-19 Advisory Board

SEARCH

TOPICS

ARCHIVES

RECENT POSTS

Previous PostVenatorx Pharmaceuticals Names William Sargent Senior Vice President, Commercial Strategy

Next PostMelior Pharmaceuticals Awarded Grant for Advancing Pulmonary Therapeutic in COVID-19 Phase 2 Clinical Trial